Search results
Found 1079 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Research reveals the first molecular understanding of BIRC6 – an essential regulator of cell death
General Research
21 February 2023
Researchers from Nuffield Department of Medicine, Department of Biochemistry and CAMS Oxford Institute uncover how BIRC6 (a giant ubiquitin ligase) protects cells from death and how this can be antagonised.
Major trials to test effectiveness of cannabidiol on psychosis
Awards and Appointments Clinical Trials General Research
16 February 2023
A global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.
Beta blockers: how these common heart medications may reduce the risk of violence
General Research
8 February 2023
NICE recommends digital mental health technologies from Oxford
General Innovation Research
8 February 2023
Two digital tools were recommended for use in the NHS to help children and young people with symptoms of anxiety or low mood.
Professor Andrea Cipriani and the search for a revolution in mental health treatments - and an organ to play
General Research
6 February 2023
It may not be quite time to throw out the psychiatrist’s couch, but Oxford Professor of Psychiatry Andrea Cipriani is hoping his research might transform the traditional approach to mental health treatment.
Communication at the crossroads of the immune system
General Research
6 February 2023
In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.
Oxford spinout trials revolutionary bioelectronic implant to treat incontinence
Clinical Trials General Innovation Research
1 February 2023
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.
COVID-19 is a leading cause of death in children and young people in the US
Coronavirus COVID-19 General Research
31 January 2023
A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.
Three or more concussions linked with worse brain function in later life
General Research
31 January 2023
Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.
New blood test could save lives of heart attack victims
General Research
31 January 2023
Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.
COVID-19 increased public trust in science, new survey shows
Coronavirus COVID-19 General Research
26 January 2023
A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.
New global health grant to improve outcomes for patients with hip fracture
General Research
26 January 2023
Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.
Major funding for Oxford will help find new cancer treatments
Awards and Appointments General Research
23 January 2023
Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
New study reveals role of lymphatic system in bone healing
General Research
19 January 2023
It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant
Coronavirus COVID-19 General Research
17 January 2023
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.
Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people
Clinical Trials General Research
3 January 2023
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
General Research
16 December 2022
New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Oxford Ebola vaccine manufactured and shipped in record time by SII
General Research
16 December 2022
More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
‘Thinking Family’ when an adult has a serious illness
General Research
15 December 2022
Every day, thousands of parents and grandparents are diagnosed with serious health conditions such as cancer, lung or heart disease. They are then faced with the unenviable task of sharing this information with the children they love.
Nearly 1 in 10 young people experience physical pain and suicidality
General Research
14 December 2022
Nearly one in 10 young people are experiencing both persistent physical pain and suicidal feelings, according to a new paper from researchers from the University of Oxford, Cambridge, Oslo (Norway), King’s College London, and the Parc Sanitari Sant Joan de Deu (Spain).